Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2023-05-08 Director's Dealing
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
112年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, executives, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of financial statements, earnings data, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, not just an announcement or summary.
2023-05-08 Chinese
112年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 生達化學製藥股份有限公司. It lists share counts held by directors, independent directors, senior management, and major shareholders, including pledged shares and shares held by spouses or minors. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not a report of a meeting, earnings release, or capital change. The content matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 2408 characters, which is consistent with a detailed insider shareholding disclosure rather than a full financial report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-05-08 Chinese
澄清媒體有關本公司報導
Regulatory Filings Classification · 95% confidence The document is a short announcement (741 characters) from a company clarifying media reports about its financial performance. It explicitly states that the company has not issued any financial forecasts and clarifies that the media and analysts' estimates are not official. There is no detailed financial data, no report attached, and no regulatory form referenced. The document serves as a regulatory announcement to clarify information rather than a full financial report or earnings release. Given its nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-21 Chinese
112年04月法人說明會簡報 — 172020230419E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation from Standard Chem & Pharm Co., Ltd. dated 04/20/2023, titled '2023 Investor Conference'. It includes an agenda with topics such as 2022 Operating Results, Future Operation Strategy, and Corporate Social Responsibility. The content contains consolidated income statements, balance sheets, and multi-year quarterly revenue comparisons, indicating substantive financial data and analysis. The length is about 15,000 characters, which is substantial and not a mere announcement or certification. The format and content align with an investor presentation focusing on financials, strategy, and market position rather than a formal annual report or earnings release. Therefore, the document best fits the category of Investor Presentation (IP).
2023-04-19 Chinese
112年04月法人說明會簡報 — 172020230419M001.pdf
Annual Report Classification · 95% confidence The document is titled as a 2023 corporate presentation by Standard Chem & Pharm Co., Ltd. It includes detailed financial data such as consolidated income statements, balance sheets, cash flow statements for the year 2022, and discusses operational results, future strategies, and corporate social responsibility. The presence of detailed financial tables and analysis for the full year 2022 indicates this is a comprehensive annual financial report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or presentation. There is no indication that this is merely an announcement of a report or a certification. The content aligns with the definition of an Annual Report (10-K) as it covers company activity and full financial performance for the year 2022.
2023-04-19 Chinese
112年04月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, summary of the presentation, and links to presentation files and video streams. It is not a full report but rather information about a scheduled or held investor presentation event. The presence of presentation files and video links strongly indicates this is related to an Investor Presentation. The document length is short (1025 characters), but it contains substantive information about the presentation itself, not just an announcement of a report publication. Therefore, the best classification is Investor Presentation (IP).
2023-04-19 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.